Ani Pharmaceuticals (ANIP) EBITDA (2011 - 2026)
Ani Pharmaceuticals' EBITDA came in at $60.1 million for Q2 2026, up 61.7% from $37.17 million a year earlier and up 0.5% from the prior quarter.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) EBITDA (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ani Pharmaceuticals reported EBITDA of $236.16 million, up 136.8% year-over-year; for FY2025, it came in at $202.51 million, up 196.4% from FY2024.
- EBITDA carries a five-year compound annual growth rate of 47.9% (FY2020 to FY2025).
- Going back by year, EBITDA was $68.32 million in FY2024 (-36.0%), $106.76 million in FY2023 (+338.1%), $24.37 million in FY2022 (+226.7%) and $7.46 million in FY2021 (-73.9%).
- The Q2 2026 figure represents the highest quarterly EBITDA in data going back to Q3 2011.
- Year-over-year, EBITDA has increased for three consecutive quarters, with growth averaging 68.2% over the last six quarters.
- The fastest year-over-year change in EBITDA over five years came in Q3 2023 (growth of 261.5%), and the weakest in Q3 2021 (a decline of 45.0%).
- Business Quant data shows ANIP's EBITDA at $59.81 million (Q1 2026), $57.38 million (Q4 2025) and $58.87 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,158.56 Bn | 1,127.15 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 625.11 Bn | 543.63 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 510.90 Bn | 484.01 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 366.23 Bn | 320.60 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.31 Bn | 261.30 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.14 Bn | 234.82 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 234.96 Bn | 190.36 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 171.63 Bn | 118.27 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Ani Pharmaceuticals | 1.54 Bn | 324.74 Mn | 165.89 Mn | 60.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60.46 Mn |
| Mar 31, 2026 | 60.17 Mn |
| Dec 31, 2025 | 57.73 Mn |
| Sep 30, 2025 | 59.21 Mn |
| Jun 30, 2025 | 37.51 Mn |
| Mar 31, 2025 | 49.41 Mn |
| Dec 31, 2024 | 18.55 Mn |
| Sep 30, 2024 | -4.65 Mn |
| Jun 30, 2024 | 20.46 Mn |
| Mar 31, 2024 | 35.10 Mn |
| Dec 31, 2023 | 22.87 Mn |
| Sep 30, 2023 | 33.75 Mn |
| Jun 30, 2023 | 27.68 Mn |
| Mar 31, 2023 | 25.58 Mn |
| Dec 31, 2022 | 18.39 Mn |
| Sep 30, 2022 | 9.76 Mn |
| Jun 30, 2022 | 1.44 Mn |
| Mar 31, 2022 | -3.66 Mn |
| Dec 31, 2021 | -9.25 Mn |
| Sep 30, 2021 | 8.36 Mn |
API Access
Ani Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ANIP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();